X0202 SCHEDULE 13G/A 0000935836-26-000106 0001105806 XXXXXXXX LIVE 7 Common Stock 03/31/2026 0001178697 DNA X, Inc. 83548F309 4445 EASTGATE MALL SUITE 200 SAN DIEGO CA 92121 Rule 13d-1(c) LYTTON LAURENCE W X1 81469.00 38888.00 81469.00 38888.00 120357.00 N 8.1 IN The shares of Common Stock beneficially owned by the reporting person excludes warrants to purchase 22,222 shares of Common Stock, which are subject to a 4.99% beneficial ownership limitation. The percentage reported herein is calculated based on 1,488,268 shares of Common Stock outstanding on April 21, 2026, as reported in the Form 10-K/A filed by the issuer for the fiscal year ended December 31, 2025. DNA X, Inc. 4445 Eastgate Mall, Suite 200, San Diego, CA 92121 Laurence W. Lytton 467 CENTRAL PARK WEST, NEW YORK, NY 10025 United States Y 120,357 8.1% 81,469 38,888 81,469 38,888 Y Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. LYTTON LAURENCE W /s/ Laurence W. Lytton 05/15/2026